Krystal Biotech Inc KRYS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:20 AM EDT
77.98quote price arrow down-0.71 (-0.90%)
Volume
11,807
52 week range
37.68 - 87.29

...

Loading . . .
  • Open79.36
  • Day High80.00
  • Day Low77.12
  • Prev Close78.69
  • 52 Week High87.29
  • 52 Week High Date03/01/21
  • 52 Week Low37.68
  • 52 Week Low Date07/13/20

Key Stats

  • Market Cap1.731B
  • Shares Out22.20M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change28.53

KEY STATS

  • Open79.36
  • Day High80.00
  • Day Low77.12
  • Prev Close78.69
  • 52 Week High87.29
  • 52 Week High Date03/01/21
  • 52 Week Low37.68
  • 52 Week Low Date07/13/20
  • Market Cap1.731B
  • Shares Out22.20M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change28.53

RATIOS/PROFITABILITY

  • EPS (TTM)-1.69
  • P/E (TTM)-46.02
  • Fwd P/E (NTM)-27.34
  • EBITDA (MRQ)-31.472M
  • ROE (MRQ)-13.00%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/06/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Krystal Biotech Inc

There is no recent news for this security.

Profile

MORE
Krystal Biotech, Inc. is a clinical-stage gene therapy company. The Company is using its proprietary Skin TARgeted Delivery (STAR-D) platform to develop treatments for skin diseases. The Company’s products are directed to the treatment of monogenic and congenital skin diseases, including dystrophic epidermolysis bullosa (DEB) and autosomal recessive congenital ichthyosis (ARCI). DEB is an incurable, often fatal skin blistering condition caused by mutations in the gene...
Krish Krishnan
Chairman
Kathryn Romano CPA
Chief Accounting Officer
Address
2100 Wharton St Ste 701
Pittsburgh, PA
15203-1973
United States

Top Peers

SYMBOLLASTCHG%CHG
SAVA
Cassava Sciences Inc
38.80+2.72+7.54%
REPL
Replimune Group Inc
31.32+0.77+2.52%
INO
Inovio Pharmaceuticals Inc
6.82-2.31-25.30%
KROS
Keros Therapeutics Inc
62.89-0.13-0.21%
ALEC
Alector Inc
18.60-0.30-1.59%